SymphoRNA

Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)

Operator of a novel cultivated-protein production process designed to create animal-cell-derived meat without conventional livestock. SymphoRNA is based in Cambridge, United Kingdom and was founded in 2017. Its last known valuation is $98.4 million. It has raised $49.2 million.

Last price · $/share
—
Implied valuation
$98.4M
Total raised
$49.2M
Last round
—

Who backs SymphoRNA?

22 investors
InvestorType
Global BrainVenture capital
MicroVenturesVenture capital
Lowercarbon CapitalVenture capital
Balderton CapitalOther
RedalpineVenture capital
Molini Besozzi MarzoliVenture capital
Apollo Projects—
East Innovate—
East XHedge fund
Angel Academe—
+ 12 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

SymphoRNA investors

22 investors are on record for SymphoRNA, including Global Brain, MicroVentures, Lowercarbon Capital and Balderton Capital. By type, the record holds 5 venture capital firms and 1 hedge fund.

Free account
More of SymphoRNA with a free account
  • ·The complete investor list: 22 names
  • ·Watch SymphoRNA: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 22 firms already write checks for companies like SymphoRNA. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View